{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T14:40:09Z","timestamp":1761489609800,"version":"build-2065373602"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["celltherapyjournal.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytotherapy"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/j.jcyt.2015.03.006","type":"journal-article","created":{"date-parts":[[2015,3,25]],"date-time":"2015-03-25T14:24:03Z","timestamp":1427293443000},"page":"786-795","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Placenta-based therapies for the treatment of epidermolysis bullosa"],"prefix":"10.1016","volume":"17","author":[{"given":"Christopher","family":"Nevala-Plagemann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jakub","family":"Tolar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcyt.2015.03.006_bib1","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.jaad.2014.01.903","article-title":"Inherited epidermolysis bullosa: updated recommendations on diagnosis and classification","volume":"70","author":"Fine","year":"2014","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.det.2009.10.020","article-title":"Dystrophic epidermolysis bullosa: pathogenesis and clinical features","volume":"28","author":"Bruckner-Tuderman","year":"2010","journal-title":"Dermatol Clin"},{"key":"10.1016\/j.jcyt.2015.03.006_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40257-013-0059-z","article-title":"Treatment of hereditary epidermolysis bullosa: updates and future prospects","volume":"15","author":"Hsu","year":"2014","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib4","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1056\/NEJMoa0910501","article-title":"Bone marrow transplantation for recessive dystrophic epidermolysis bullosa","volume":"363","author":"Wagner","year":"2010","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2015.03.006_bib5","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJMcibr1414709","article-title":"A\u00a0biologic Velcro patch","volume":"372","author":"Tolar","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jcyt.2015.03.006_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1126\/science.1191536","article-title":"Aryl hydrocarbon receptor antagonists promote the expansion of human hematopoietic stem cells","volume":"329","author":"Boitano","year":"2010","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2015.03.006_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MOP.0000000000000179","article-title":"Advances in unrelated and alternative donor hematopoietic cell transplantation for nonmalignant disorders","volume":"27","author":"Shenoy","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jcyt.2015.03.006_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1182\/asheducation.V2012.1.215.3798291","article-title":"Umbilical cord blood transplantation: a maturing technology","volume":"2012","author":"Oran","year":"2012","journal-title":"Hematology Am Soc Hematol Educ Program"},{"key":"10.1016\/j.jcyt.2015.03.006_bib9","first-page":"572821","article-title":"Insights and hopes in umbilical cord blood stem cell transplantations","volume":"2012","author":"Shahrokhi","year":"2012","journal-title":"J\u00a0Biomed Biotechnol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib10","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1182\/blood-2013-02-453175","article-title":"Umbilical cord blood transplantation: the first 25 years and beyond","volume":"122","author":"Ballen","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.006_bib11","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jpeds.2007.04.054","article-title":"Hematopoietic cell therapy for metabolic disease","volume":"151","author":"Orchard","year":"2007","journal-title":"J\u00a0Pediatr"},{"key":"10.1016\/j.jcyt.2015.03.006_bib12","doi-asserted-by":"crossref","first-page":"803","DOI":"10.2353\/ajpath.2008.070977","article-title":"Bone marrow cell transfer into fetal circulation can ameliorate genetic skin diseases by providing fibroblasts to the skin and inducing immune tolerance","volume":"173","author":"Chino","year":"2008","journal-title":"Am J Pathol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib13","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1182\/blood-2008-06-161299","article-title":"Amelioration of epidermolysis bullosa by transfer of wild-type bone marrow cells","volume":"113","author":"Tolar","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.006_bib14","doi-asserted-by":"crossref","first-page":"14345","DOI":"10.1073\/pnas.1000044107","article-title":"Bone marrow transplantation restores epidermal basement membrane protein expression and rescues epidermolysis bullosa model mice","volume":"107","author":"Fujita","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2015.03.006_bib15","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1002\/stem.647","article-title":"Concise review: Transplantation of human hematopoietic cells for extracellular matrix protein deficiency in epidermolysis bullosa","volume":"29","author":"Tolar","year":"2011","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.03.006_bib16","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1182\/blood-2006-07-033902","article-title":"Donor-derived cells and human graft-versus-host disease of the skin","volume":"109","author":"Murata","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.006_bib17","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/j.bbmt.2010.07.012","article-title":"Nasal epithelial cells of donor origin after allogeneic hematopoietic cell transplantation are generated at a faster rate in the first 3 months compared with later posttransplantation","volume":"16","author":"Khan","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.006_bib18","doi-asserted-by":"crossref","first-page":"6609","DOI":"10.1073\/pnas.1016753108","article-title":"PDGFRalpha-positive cells in bone marrow are mobilized by high mobility group box 1 (HMGB1) to regenerate injured epithelia","volume":"108","author":"Tamai","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/j.jcyt.2015.03.006_bib19","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.4049\/jimmunol.1400914","article-title":"Transplanted Bone Marrow-Derived Circulating PDGFRalpha+ Cells Restore Type VII Collagen in Recessive Dystrophic Epidermolysis Bullosa Mouse Skin Graft","volume":"194","author":"Iinuma","year":"2015","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib20","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.03.006_bib21","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1146\/annurev-immunol-032712-095919","article-title":"Mesenchymal stem cell: keystone of the hematopoietic stem cell niche and a stepping-stone for regenerative medicine","volume":"31","author":"Frenette","year":"2013","journal-title":"Annu Rev Immunol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib22","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12015-009-9102-0","article-title":"Promising new sources for pluripotent stem cells","volume":"6","author":"Leeb","year":"2010","journal-title":"Stem Cell Rev"},{"key":"10.1016\/j.jcyt.2015.03.006_bib23","first-page":"248","article-title":"Bone marrow and umbilical cord blood human mesenchymal stem cells: state of the art","volume":"3","author":"Malgieri","year":"2010","journal-title":"Int J Clin Exp Med"},{"key":"10.1016\/j.jcyt.2015.03.006_bib24","first-page":"274","article-title":"Potential uses for cord blood mesenchymal stem cells","volume":"15","author":"Zarrabi","year":"2014","journal-title":"Cell J"},{"key":"10.1016\/j.jcyt.2015.03.006_bib25","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1634\/stemcells.22-4-625","article-title":"Critical parameters for the isolation of mesenchymal stem cells from umbilical cord blood","volume":"22","author":"Bieback","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.03.006_bib26","first-page":"1017","article-title":"Isolation and characterization of human umbilical cord mesenchymal stem cells with hematopoiesis-supportive function and other potentials","volume":"91","author":"Lu","year":"2006","journal-title":"Haematologica"},{"key":"10.1016\/j.jcyt.2015.03.006_bib27","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1634\/stemcells.2006-0709","article-title":"Comparison of proliferative and multilineage differentiation potential of human mesenchymal stem cells derived from umbilical cord and bone marrow","volume":"25","author":"Baksh","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.03.006_bib28","doi-asserted-by":"crossref","first-page":"916136","DOI":"10.1155\/2013\/916136","article-title":"Isolation and characterisation of mesenchymal stem cells from different regions of the human umbilical cord","volume":"2013","author":"Mennan","year":"2013","journal-title":"Biomed Res Int"},{"key":"10.1016\/j.jcyt.2015.03.006_bib29","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1634\/stemcells.22-5-812","article-title":"Contribution of bone marrow-derived cells to skin: collagen deposition and wound repair","volume":"22","author":"Fathke","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.03.006_bib30","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s00441-006-0270-9","article-title":"Adult bone-marrow-derived mesenchymal stem cells contribute to wound healing of skin appendages","volume":"326","author":"Li","year":"2006","journal-title":"Cell Tissue Res"},{"key":"10.1016\/j.jcyt.2015.03.006_bib31","doi-asserted-by":"crossref","first-page":"2648","DOI":"10.1634\/stemcells.2007-0226","article-title":"Mesenchymal stem cells enhance wound healing through differentiation and angiogenesis","volume":"25","author":"Wu","year":"2007","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.03.006_bib32","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.4049\/jimmunol.180.4.2581","article-title":"Mesenchymal stem cells are recruited into wounded skin and contribute to wound repair by transdifferentiation into multiple skin cell type","volume":"180","author":"Sasaki","year":"2008","journal-title":"J\u00a0Immunol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib33","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.jcyt.2012.11.006","article-title":"Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues","volume":"15","author":"Alexeev","year":"2013","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.03.006_bib34","doi-asserted-by":"crossref","first-page":"429","DOI":"10.3109\/14653241003587637","article-title":"Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa","volume":"12","author":"Conget","year":"2010","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.03.006_bib35","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1111\/j.1524-475X.2010.00616.x","article-title":"Promotion of cutaneous wound healing by local application of mesenchymal stem cells derived from human umbilical cord blood","volume":"18","author":"Luo","year":"2010","journal-title":"Wound Repair Regen"},{"key":"10.1016\/j.jcyt.2015.03.006_bib36","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1159\/000329234","article-title":"Priming of mesenchymal stem cells with oxytocin enhances the cardiac repair in ischemia\/reperfusion injury","volume":"195","author":"Kim","year":"2012","journal-title":"Cells Tissues Organs"},{"key":"10.1016\/j.jcyt.2015.03.006_bib37","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1080\/14653240701584578","article-title":"UC blood-derived mesenchymal stromal cells: an overview","volume":"9","author":"Flynn","year":"2007","journal-title":"Cytotherapy"},{"key":"10.1016\/j.jcyt.2015.03.006_bib38","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1634\/stemcells.2004-0024","article-title":"Comparison of gene expression of umbilical cord vein and bone marrow-derived mesenchymal stem cells","volume":"22","author":"Panepucci","year":"2004","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.03.006_bib39","doi-asserted-by":"crossref","first-page":"2607","DOI":"10.1002\/pmic.201200111","article-title":"A\u00a0quantitative proteomic and transcriptomic comparison of human mesenchymal stem cells from bone marrow and umbilical cord vein","volume":"12","author":"Miranda","year":"2012","journal-title":"Proteomics"},{"key":"10.1016\/j.jcyt.2015.03.006_bib40","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1080\/08916930802200166","article-title":"Is there a role for mesenchymal stem cells in autoimmune diseases?","volume":"41","author":"Uccelli","year":"2008","journal-title":"Autoimmunity"},{"key":"10.1016\/j.jcyt.2015.03.006_bib41","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nri3209","article-title":"Multipotent mesenchymal stromal cells and the innate immune system","volume":"12","author":"Le Blanc","year":"2012","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib42","doi-asserted-by":"crossref","first-page":"3147","DOI":"10.1089\/scd.2012.0214","article-title":"Treatment of familial hemophagocytic lymphohistiocytosis with third-party mesenchymal stromal cells","volume":"21","author":"Mougiakakos","year":"2012","journal-title":"Stem Cells Dev"},{"key":"10.1016\/j.jcyt.2015.03.006_bib43","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/S0140-6736(04)16104-7","article-title":"Treatment of severe acute graft-versus-host disease with third party haploidentical mesenchymal stem cells","volume":"363","author":"Le Blanc","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/j.jcyt.2015.03.006_bib44","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1097\/01.tp.0000214462.63943.14","article-title":"Mesenchymal stem cells for treatment of therapy-resistant graft-versus-host disease","volume":"81","author":"Ringden","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.jcyt.2015.03.006_bib45","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/bmt.2013.237","article-title":"Stromal cells-are they really useful for GVHD?","volume":"49","author":"Kaipe","year":"2014","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/j.jcyt.2015.03.006_bib46","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1634\/stemcells.2006-0071","article-title":"Placenta-derived multipotent cells exhibit immunosuppressive properties that are enhanced in the presence of interferon-gamma","volume":"24","author":"Chang","year":"2006","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.03.006_bib47","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.humimm.2008.10.016","article-title":"Differential immunomodulatory effects of fetal versus maternal multipotent stromal cells","volume":"70","author":"Roelen","year":"2009","journal-title":"Hum Immunol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib48","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1111\/j.1365-2249.2011.04540.x","article-title":"Stromal cells from term fetal membrane are highly suppressive in allogeneic settings in\u00a0vitro","volume":"167","author":"Karlsson","year":"2012","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib49","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1084\/jem.20040440","article-title":"A\u00a0new human somatic stem cell from placental cord blood with intrinsic pluripotent differentiation potential","volume":"200","author":"Kogler","year":"2004","journal-title":"J\u00a0Exp Med"},{"key":"10.1016\/j.jcyt.2015.03.006_bib50","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/cpr.12070","article-title":"Taha T: Enhancing ex\u00a0vivo expansion of cord blood-derived unrestricted somatic stem cells for clinical applications","volume":"46","author":"Demerdash","year":"2013","journal-title":"Cell Prolif"},{"key":"10.1016\/j.jcyt.2015.03.006_bib51","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3727\/096368913X663569","article-title":"Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa","volume":"23","author":"Liao","year":"2014","journal-title":"Cell Transplant"},{"key":"10.1016\/j.jcyt.2015.03.006_bib52","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.cell.2006.07.024","article-title":"Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors","volume":"126","author":"Takahashi","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.jcyt.2015.03.006_bib53","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1038\/jid.2010.346","article-title":"Induced pluripotent stem cells from individuals with recessive dystrophic epidermolysis bullosa","volume":"131","author":"Tolar","year":"2011","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib54","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1038\/mt.2013.56","article-title":"TALEN-based gene correction for epidermolysis bullosa","volume":"21","author":"Osborn","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2015.03.006_bib55","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1038\/jid.2013.523","article-title":"Patient-specific naturally gene-reverted induced pluripotent stem cells in recessive dystrophic epidermolysis bullosa","volume":"134","author":"Tolar","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib56","doi-asserted-by":"crossref","first-page":"264ra163","DOI":"10.1126\/scitranslmed.3009540","article-title":"Human COL7A1-corrected induced pluripotent stem cells for the treatment of recessive dystrophic epidermolysis bullosa","volume":"6","author":"Sebastiano","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.jcyt.2015.03.006_bib57","unstructured":"2014. World's First Induced Pluripotent Stem Cells Clinical Study on Humans Launches in Japan [News]. Available from http:\/\/stemcellstm.alphamedpress.org\/site\/misc\/News159.xhtml."},{"key":"10.1016\/j.jcyt.2015.03.006_bib58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1002\/stem.1293","article-title":"An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells","volume":"31","author":"Okita","year":"2013","journal-title":"Stem Cells"},{"key":"10.1016\/j.jcyt.2015.03.006_bib59","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.exphem.2010.05.009","article-title":"Induction of pluripotency in human cord blood unrestricted somatic stem cells","volume":"38","author":"Zaehres","year":"2010","journal-title":"Exp Hematol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib60","doi-asserted-by":"crossref","first-page":"3693","DOI":"10.1007\/s11033-012-2445-7","article-title":"A\u00a0comparison of pluripotency and differentiation status of four mesenchymal adult stem cells","volume":"40","author":"Adegani","year":"2013","journal-title":"Mol Biol Rep"},{"key":"10.1016\/j.jcyt.2015.03.006_bib61","doi-asserted-by":"crossref","first-page":"4773","DOI":"10.1182\/blood-2011-01-330514","article-title":"Hematopoietic stem\/progenitor cells, generation of induced pluripotent stem cells, and isolation of endothelial progenitors from 21- to 23.5-year cryopreserved cord blood","volume":"117","author":"Broxmeyer","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jcyt.2015.03.006_bib62","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.gpb.2013.08.002","article-title":"Generation of induced pluripotent stem cells with high efficiency from human umbilical cord blood mononuclear cells","volume":"11","author":"Wang","year":"2013","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"10.1016\/j.jcyt.2015.03.006_bib63","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1586\/ehm.10.24","article-title":"Strategies to enhance umbilical cord blood stem cell engraftment in adult patients","volume":"3","author":"Delaney","year":"2010","journal-title":"Expert Rev Hematol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib64","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/sj.leu.2404631","article-title":"Telomere length of cord blood-derived CD34(+) progenitors predicts erythroid proliferative potential","volume":"21","author":"Schuller","year":"2007","journal-title":"Leukemia"},{"key":"10.1016\/j.jcyt.2015.03.006_bib65","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/0921-8734(92)90020-P","article-title":"Deleterious mitochondrial DNA mutations accumulate in aging human tissues","volume":"275","author":"Arnheim","year":"1992","journal-title":"Mutat Res"},{"key":"10.1016\/j.jcyt.2015.03.006_bib66","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1016\/S0047-6374(02)00090-8","article-title":"Mutation theory of aging, assessed in transgenic mice and knockout mice","volume":"123","author":"Ono","year":"2002","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/j.jcyt.2015.03.006_bib67","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1260825","article-title":"Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti","year":"2015","journal-title":"Science"},{"key":"10.1016\/j.jcyt.2015.03.006_bib68","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1038\/jid.2014.209","article-title":"Augmentation of cutaneous wound healing by pharmacologic mobilization of endogenous bone marrow stem cells","volume":"134","author":"Tolar","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib69","doi-asserted-by":"crossref","first-page":"2458","DOI":"10.1038\/jid.2014.162","article-title":"Pharmacological mobilization of endogenous stem cells significantly promotes skin regeneration after full-thickness excision: the synergistic activity of AMD3100 and tacrolimus","volume":"134","author":"Lin","year":"2014","journal-title":"J\u00a0Invest Dermatol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib70","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1038\/nbt.2052","article-title":"Donor cell type can influence the epigenome and differentiation potential of human induced pluripotent stem cells","volume":"29","author":"Kim","year":"2011","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib71","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.1074\/jbc.M113.538702","article-title":"MicroRNAs contribute to induced pluripotent stem cell somatic donor memory","volume":"289","author":"Vitaloni","year":"2014","journal-title":"J\u00a0Biol Chem"},{"key":"10.1016\/j.jcyt.2015.03.006_bib72","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/mt.2013.71","article-title":"Generation of engraftable hematopoietic stem cells from induced pluripotent stem cells by way of teratoma formation","volume":"21","author":"Suzuki","year":"2013","journal-title":"Mol Ther"},{"key":"10.1016\/j.jcyt.2015.03.006_bib73","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/j.jaad.2009.02.048","article-title":"Amniotic membrane grafting in patients with epidermolysis bullosa with chronic wounds","volume":"62","author":"Lo","year":"2010","journal-title":"J\u00a0Am Acad Dermatol"},{"key":"10.1016\/j.jcyt.2015.03.006_bib74","first-page":"68","article-title":"Autologel Diabetic Foot Ulcer Study G: A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers","volume":"52","author":"Driver","year":"2006","journal-title":"Ostomy Wound Manage"},{"key":"10.1016\/j.jcyt.2015.03.006_bib75","doi-asserted-by":"crossref","first-page":"549","DOI":"10.3109\/09537104.2010.514626","article-title":"Platelet gel from cord blood: a novel tool for tissue engineering","volume":"21","author":"Parazzi","year":"2010","journal-title":"Platelets"},{"key":"10.1016\/j.jcyt.2015.03.006_bib76","first-page":"153","article-title":"Preliminary evaluation of cord blood platelet gel for the treatment of skin lesions in children with dystrophic epidermolysis bullosa","volume":"13","author":"Tadini","year":"2015","journal-title":"Blood Transfus"},{"key":"10.1016\/j.jcyt.2015.03.006_bib77","first-page":"1","article-title":"A\u00a0living band-aid for epidermolysis bullosa","volume":"13","author":"Tolar","year":"2015","journal-title":"Blood Transfus"}],"container-title":["Cytotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915000900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1465324915000900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T22:21:23Z","timestamp":1761430883000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1465324915000900"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S1465324915000900"],"URL":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.03.006","relation":{},"ISSN":["1465-3249"],"issn-type":[{"type":"print","value":"1465-3249"}],"subject":[],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Placenta-based therapies for the treatment of epidermolysis bullosa","name":"articletitle","label":"Article Title"},{"value":"Cytotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcyt.2015.03.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for Cellular Therapy. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}